Document Report Card

Basic Information

ID: ALA3588744

Journal: J Med Chem

Title: Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors.

Authors: Bamborough P, Chung CW, Furze RC, Grandi P, Michon AM, Sheppard RJ, Barnett H, Diallo H, Dixon DP, Douault C, Jones EJ, Karamshi B, Mitchell DJ, Prinjha RK, Rau C, Watson RJ, Werner T, Demont EH.

Abstract: ATAD2 is a bromodomain-containing protein whose overexpression is linked to poor outcomes in a number of different cancer types. To date, no potent and selective inhibitors of the bromodomain have been reported. This article describes the structure-based optimization of a series of naphthyridones from micromolar leads with no selectivity over the BET bromodomains to inhibitors with sub-100 nM ATAD2 potency and 100-fold BET selectivity.

CiteXplore: 26230603

DOI: 10.1021/acs.jmedchem.5b00773